NuVasive Inc - Company Profile
Powered by
All the data and insights you need on NuVasive Inc in one report.
- Save hours of research time and resources with
our up-to-date NuVasive Inc Strategy Report
- Understand NuVasive Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
NuVasive Inc (NuVasive) is a medical device company which offers minimally invasive, procedurally integrated spine solutions. The company’s products are focused on the therapy areas related to degenerative disc disease, lumbar spinal stenosis, degenerative spondylolisthesis, cervical disc degeneration, early onset scoliosis, and limb length discrepancy, among others. The company provides eXtreme Lateral Interbody Fusion procedure (XLIF), a minimally disruptive surgical platform, which enables surgeons to perform a range of minimally disruptive spine procedures in all regions of the spine and through various surgical approaches. Its XLIF platform used in the treatment of procedures for the cervical, thoracic and lumbar spine, from the anterior, including lateral, and posterior. Its specialized implants and fixation products and its nerve monitoring systems and service offerings. The company offers implants, fixation products, intraoperative monitoring (IOM) services, disposables, and biologics for use in spinal surgery. NuVasive is headquartered in San Diego, California, the US.
NuVasive Inc premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
- | Pulse | Absolute Responsiveness |
Surgical Access Instruments | Simplify | Advanced Materials Science |
Spinal Implants | Clinical Services | Acuity |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Acquisitions/Mergers/Takeovers | In September, the company merged with Globus Medical. |
2023 | Regulatory Approval | In April, the company secured shareholders approval to merge with Globus Medical. |
2023 | Regulatory Approval | In March, the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of its Precice all-internal limb lengthening solution to include pediatric patients. |
Competitor Comparison
Key Parameters | NuVasive Inc | Medtronic Plc | DePuy Synthes Inc | Smith & Nephew Plc | Integra LifeSciences Holdings Corp |
---|---|---|---|---|---|
Headquarters | United States of America | Ireland | United States of America | United Kingdom | United States of America |
City | San Diego | Dublin | Warsaw | Watford | Princeton |
State/Province | California | - | Indiana | England | New Jersey |
No. of Employees | 3,000 | 95,000 | 18,000 | 19,000 | 3,722 |
Entity Type | Private | Public | Private | Public | Public |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
J. Christopher Barry | Director; Chief Executive Officer | Executive Board | 2018 | 50 |
Matthew K. Harbaugh | Executive Vice President; Chief Financial Officer | Senior Management | 2020 | 52 |
Ryan Donahoe | Chief Technology Officer; Senior Vice President | Senior Management | 2021 | - |
Daniel J. Wolterman | Chairman | Non Executive Board | 2021 | 66 |
Marc Rosenbaum | Chief Accounting Officer; Vice President; Corporate Controller | Senior Management | 2022 | - |
Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward